B y now, most people have reached a resigned acceptance when it comes to COVID-19. We accept that we’re probably going to get infected at some point during respiratory disease season—and that when we do, we’ll feel sick for a couple of days, and then get over it. But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San Francisco, researchers reported that

Tag-uri: Coronavirus